TechCN

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical

KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling in Germany/Switzerland Basel,......